GLP-1s Just Got More Powerful, And Pharmacists Are Now Indispensable to Their Success
This week at the APhA Annual Meeting 2026 in Los Angeles, the GLP-1 conversation evolved significantly, and pharmacists are at the center of…
A Daily Pill Just Matched Injectable PCSK9 Inhibitors at Cutting LDL by 57%, and It Changes Everything About Adherence
An oral pill delivers injectable-level LDL lowering, here’s why it matters. A landmark trial just changed the lipid management conversation If…
The $5 a Month Drug That May Be the Most Powerful Anti-Aging Molecule We’ve Ever Had
Is this the closest thing we have to an anti-aging pill? What if the real anti-aging breakthrough is already on your pharmacy shelf? Let’s set…
A Quiet Shift: What A New Trial Reveals About Apixaban and Rivaroxaban for VTE
Preview: New evidence challenges DOAC interchangeability for VTE care When it comes to treating venous thromboembolism (VTE), I’ve often heard…